Charles Schwab’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.87M | Buy |
1,253,829
+31,764
| +3% | +$98.2K | ﹤0.01% | 2437 |
|
|
2025
Q1 | $4.27M | Sell |
1,222,065
-136
| -0% | -$475 | ﹤0.01% | 2332 |
|
|
2024
Q4 | $4M | Buy |
1,222,201
+9,955
| +0.8% | +$32.6K | ﹤0.01% | 2439 |
|
|
2024
Q3 | $4.67M | Buy |
1,212,246
+831,663
| +219% | +$3.2M | ﹤0.01% | 2407 |
|
|
2024
Q2 | $1.18M | Buy |
380,583
+41,368
| +12% | +$128K | ﹤0.01% | 2864 |
|
|
2024
Q1 | $875K | Sell |
339,215
-10,143
| -3% | -$26.2K | ﹤0.01% | 2835 |
|
|
2023
Q4 | $873K | Hold |
349,358
| – | – | ﹤0.01% | 2877 |
|
|
2023
Q3 | $709K | Buy |
349,358
+13,285
| +4% | +$27K | ﹤0.01% | 2916 |
|
|
2023
Q2 | $773K | Buy |
336,073
+27,104
| +9% | +$62.3K | ﹤0.01% | 2858 |
|
|
2023
Q1 | $936K | Buy |
308,969
+3,689
| +1% | +$11.2K | ﹤0.01% | 2754 |
|
|
2022
Q4 | $711K | Buy |
305,280
+17,861
| +6% | +$41.6K | ﹤0.01% | 2893 |
|
|
2022
Q3 | $549K | Sell |
287,419
-535
| -0.2% | -$1.02K | ﹤0.01% | 2977 |
|
|
2022
Q2 | $781K | Buy |
287,954
+48,241
| +20% | +$131K | ﹤0.01% | 2887 |
|
|
2022
Q1 | $715K | Buy |
239,713
+30,338
| +14% | +$90.5K | ﹤0.01% | 2982 |
|
|
2021
Q4 | $815K | Hold |
209,375
| – | – | ﹤0.01% | 2983 |
|
|
2021
Q3 | $899K | Buy |
209,375
+22,907
| +12% | +$98.4K | ﹤0.01% | 2913 |
|
|
2021
Q2 | $565K | Buy |
186,468
+165,556
| +792% | +$502K | ﹤0.01% | 3126 |
|
|
2021
Q1 | $70K | Hold |
20,912
| – | – | ﹤0.01% | 3410 |
|
|
2020
Q4 | $75K | Sell |
20,912
-12,000
| -36% | -$43K | ﹤0.01% | 3333 |
|
|
2020
Q3 | $104K | Buy |
+32,912
| New | +$104K | ﹤0.01% | 3247 |
|
|
2019
Q2 | – | Sell |
-65,900
| Closed | -$236K | – | 3212 |
|
|
2019
Q1 | $236K | Hold |
65,900
| – | – | ﹤0.01% | 2991 |
|
|
2018
Q4 | $253K | Hold |
65,900
| – | – | ﹤0.01% | 2978 |
|
|
2018
Q3 | $623K | Hold |
65,900
| – | – | ﹤0.01% | 2765 |
|
|
2018
Q2 | $482K | Buy |
+65,900
| New | +$482K | ﹤0.01% | 2815 |
|